Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Right. But the $12M worth of debt they racked up last quarter is bad any way you look at it. Hopefully Q1 is looking better and saw less debt added.
Correct. Everything in the PR is great news, but we need the Q to see the full picture. Cash flow positive is great, and hopefully means they didn't take on a lot more debt like last quarter.
MyDx has exclusive rights to 62 patents, and the data is useful to everyone in the industry.
MyDx posted the picture on Facebook and instagram
No, the box next to it says "Sensor Board SN", so if anything it is the 3773rd sensor...which would include new and replacement sensors. It looks like one to the right says 3787?
Last time I saw 911 trades here we got news within a few days, and the 80mil buy right before the close yesterday tells me somebody knows something. With all the presentations, demonstrations and such the company has been doing...its only a matter of time before they land something.
There have been more 911 trades today?
Hopefully you can survive the weekend, cuz I'm guessing we won't see them until Monday
Because it's only a matter of time before the tide turns. They know marijuana can get the same results most of their medications can, for less and with less side effects. That's why they fight the hardest and spend the most to oppose legalization. As medical marijuana continues to get legalized in more states and more people turn to cannabis based medications they will have to join the club. And why start from scratch when you have the money to buy technology that's already there, like a huge database linking ailments to what strains will alleviate them. Or, a company already involved with marijuana like GW Pharm, Zynerba, Insys, etc., who want to expand their technology. Yaz has already turned down buyout offers in the past, maybe he won't in the future.
Incorrect. A big Pharma company is much more likely to be interested in acquiring MyDx than Panasonic.
I would say his friends at Pfizer are a little more valuable than his friends in Canada
First day here? There has been a huge increase in international sales, especially to Canada, as already confirmed by the company long ago.
Not sure about $1 this year, but come January 2018 when California starts selling recreationally...sky's the limit.
They've been unusually quiet on twitter the last few days, could be big news coming.
While I hate to agree with Malc, I do on this point. After missing their goal on cash flow positive Q4, I see no chance of profitability in Q1. Maybe they went cash flow positive this quarter, but that's a big maybe. I think it'll depend on whether development costs for the vape pen and other new products were part of the huge $12m debt in Q4 or if more cost came in Q1.
Maybe a huge influx of orders sold them out, maybe they just didn't have that many in stock because they were waiting on new units with the 2.0 upgrades. It's all speculation until the numbers come out.
With earnings due any day, it's almost not even worth putting any effort into it to try to figure it out, but if you wanna think about it logically...
As of 2016 Q4 there were around 1500-2000 units sold. I don't remember exactly when preorders started, but let's say mid 2015. That comes out to roughly 300 units per quarter.
So if you were selling 300 units a quarter, how many would you keep in stock? 25% surplus? 50%?
I'd say somewhere around 500 units sold in Q1 is realistic, 600 at most. Add in OrganaDx and AquaDx sales and I think we'll see $300-500k revenue.
It was every 2 weeks for a while. The $35k note, if it wasn't paid off like it should have been, should have only been around 4mil shares of dilution. So hopefully when it gets updated we aren't over 1.55B OS.
On the flip side, they also "expected" to be cash flow positive Q4 and that didn't happen. Revenues obviously increased for Q1, probably significantly, but the big factor is debt. BMAK has been on the ask a lot this week as well, which makes me wonder if that last $35k note didn't get paid off and there has been some dilution. The OS has not been updated in a while, so they may be trying to hide it.
Correct, but not 1000 units worth of backorders. I'm not the one who is trying to spin anything. As I said earlier I expect a 100-300% increase in revenue over Q1 last year, which is great, as long as they were able to cut down on the debt.
911 is a MM signal for possible news. Last time it happened, we got news.
They didn't sell 1000 units, they ordered 1000 units for backorders and stock. It's still great news that they sold out and couldn't keep up with demand though, Q1 2017 will definitely beat Q1 2016, and I would assume Q4 as well. Impossible to guesd how many units they sold, but selling out of MyDx, OrganaDx and AquaDx obviously points to increased revenues. Q1 was also the first full quarter of AquaDx and OrganaDx sales. I think we'll see somewhere between 100% and 300% increase in revenue over Q1 2016, but more important than revenue is if they were able to keep the debt under control. Q4 added $12mil worth of debt, we don't need any more. I'm still confused as to where it all came from.
You realize 90% of those are from last year and already converted? VNDM is one of the main diluters, yes.
Ya know what, you're right. I think.
It goes both ways. If he would have said 1000 units "sold" people would be saying "well they sold them but can't deliver" or coming up with other excuses to bash. I'm not saying you're right or wrong, simply stating what I believe "delivered" means. Truth will come out soon in the Q.
I don't remember units being on backorder last quarter, which means every unit "delivered" in Q1 was most likely ordered in Q1. The wording on "delivered" vs "sold" could also be to show that they're actually delivering and not just taking orders as they were in the past with presales/preorders and such. If they sold out there could, and most likely were, more units sold that haven't delivered yet.
It doesn't say $1m in sales, but revenue could be very close to that. 1000 MyDx units were "delivered", meaning sold. They also sold out, which means there could have been more sales that are on backorder.
1000 units is probably around $500-700k in revenue depending on how many were purchased directly from the company vs purchased by resellers for a discount. AquaDx and OrganaDx also sold out in Q1, which could be another $50-100k or more in additional revenue. Then on top of that is replacement sensor and sample insert sales, which could have been another $100k+ revenue.
As I've pointed out in the past, every MyDx unit sold also creates recurring revenue. There should be around 2500 units sold now, with sensors needing to be replaced every 6 months. 5000 sensors at $70 each is $350k/yr. If the average user is doing 1 sample a week, that's another $200k/yr in sample inserts.
If anyone here has had contact with the CEO, please recommend a PR or at least a tweet containing launch day usage stats.
They did a lot of "fat trimming" over the last few years to eliminate people who were just sucking up salary and raising expenses. My guess is all of the "resignations" were them getting axed.
If they "delivered" 1000 units, and sold out...makes me wonder how many more units were ordered and paid for in Q1 that weren't shipped.
He definitely should have put out a PR for the app release today, it would have defi itely generated a lot more interest today. Although I'm not complaining about the couple mil I was able to add at .0008 today $$$$$
We'll find out soon. Maybe.
"Delivered" versus "sold" caught my eye as well. However, it can go either way. You can sell units without delivering them as they did with preorders, but you can't deliver units that aren't sold. There was no backorder on the MyDx units this past quarter as far as I know, so I think it's safe to say 1000 units sold and delivered. Even if theyre "delivering" units to retailers, they're still getting paid up front.
I would assume retrofitted simply means their manufacturer had completed units that were updated with the enhancements.
Tell him to stop waiting until the end of the day as well.
The PR hasn't reached all media outlets yet, only a few. Not even showing on iHub yet
1000 units delivered = $700-900k revenue. OrganaDx and AquaDx also sold out this quarter. Add in all the replacement sensors and sample inserts sold and we could be looking at $1mil+ revenue for Q1 and close to 1000% increase over Q1 2016 revenue of $161k
MyDx units SOLD OUT in Q1! Very good news. Hopefully they went cash flow positive if not profitable.
Either way, it's a drop in the bucket compared to what we've gone through in the past. And if it wasn't paid off, it was at least the last of the convertible debt. Im sure we'll find out when the Q is filed.
It's not up to him, it's up to the note holder. I'm sure they already would have dumped if the debt was not paid off. With only ~4mil shares of possible dilution, it could have happened without anybody noticing.
And OTTV will do the same tomorrow. Prime time to load up on the dip.